apoplexa limited

Converted/Closed MatureMicroDeclining

apoplexa limited Company Information

Share APOPLEXA LIMITED

Company Number

05013482

Shareholders

mr thomas mueller

Group Structure

View All

Industry

Other business support service activities n.e.c.

 

Registered Address

69 great hampton street, birmingham, west midlands, B18 6EW

Website

-

apoplexa limited Estimated Valuation

£6.2k

Pomanda estimates the enterprise value of APOPLEXA LIMITED at £6.2k based on a Turnover of £16k and 0.39x industry multiple (adjusted for size and gross margin).

apoplexa limited Estimated Valuation

£21.5k

Pomanda estimates the enterprise value of APOPLEXA LIMITED at £21.5k based on an EBITDA of £7.8k and a 2.75x industry multiple (adjusted for size and gross margin).

apoplexa limited Estimated Valuation

£40.5k

Pomanda estimates the enterprise value of APOPLEXA LIMITED at £40.5k based on Net Assets of £17.1k and 2.37x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Apoplexa Limited Overview

Apoplexa Limited is a converted/closed company that was located in west midlands, B18 6EW with a Companies House number of 05013482. It operated in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in January 2004, it's largest shareholder was mr thomas mueller with a 100% stake. The last turnover for Apoplexa Limited was estimated at £16k.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Apoplexa Limited Health Check

Pomanda's financial health check has awarded Apoplexa Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 8 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating1.5out of 5
positive_score

1 Strong

positive_score

1 Regular

positive_score

8 Weak

size

Size

annual sales of £16k, make it smaller than the average company (£2.7m)

£16k - Apoplexa Limited

£2.7m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -36%, show it is growing at a slower rate (4.4%)

-36% - Apoplexa Limited

4.4% - Industry AVG

production

Production

with a gross margin of 16.5%, this company has a higher cost of product (37.2%)

16.5% - Apoplexa Limited

37.2% - Industry AVG

profitability

Profitability

an operating margin of 48.3% make it more profitable than the average company (5.7%)

48.3% - Apoplexa Limited

5.7% - Industry AVG

employees

Employees

with 1 employees, this is below the industry average (23)

1 - Apoplexa Limited

23 - Industry AVG

paystructure

Pay Structure

on an average salary of £44.3k, the company has an equivalent pay structure (£44.3k)

£44.3k - Apoplexa Limited

£44.3k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £16k, this is less efficient (£147.9k)

£16k - Apoplexa Limited

£147.9k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 88 days, this is later than average (46 days)

88 days - Apoplexa Limited

46 days - Industry AVG

creditordays

Creditor Days

There is insufficient data available for this Key Performance Indicator!

- - Apoplexa Limited

- - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Apoplexa Limited

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 13 weeks, this is less cash available to meet short term requirements (20 weeks)

13 weeks - Apoplexa Limited

20 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 79.7%, this is a higher level of debt than the average (67.5%)

79.7% - Apoplexa Limited

67.5% - Industry AVG

APOPLEXA LIMITED financials

EXPORTms excel logo

Apoplexa Limited's latest turnover from December 2018 is estimated at £16 thousand and the company has net assets of £17.1 thousand. According to their latest financial statements, we estimate that Apoplexa Limited has 1 employee and maintains cash reserves of £17.4 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Turnover15,97305,81261,94875,66470,58794,97270,05752,3780
Other Income Or Grants0000000000
Cost Of Sales13,33304,80051,78763,54159,43479,63658,24243,2260
Gross Profit2,64001,01210,16112,12311,15315,33611,8159,1510
Admin Expenses-5,078223300-19,50820,3244,8218,87711,86811,28312,933
Operating Profit7,718-22371229,669-8,2016,3326,459-53-2,132-12,933
Interest Payable0000000000
Interest Receivable7916254261413522
Pre-Tax Profit7,797-20773729,711-8,1966,3456,472-48-2,130-12,931
Tax-1,4810-147-5,9420-1,459-1,553000
Profit After Tax6,316-20758923,769-8,1964,8864,919-48-2,130-12,931
Dividends Paid0000000000
Retained Profit6,316-20758923,769-8,1964,8864,919-48-2,130-12,931
Employee Costs44,301042,00041,65641,55741,12140,16639,59638,4830
Number Of Employees1011111110
EBITDA*7,841-1001,05730,139-6,8106,5896,794-53-2,132-12,933

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Tangible Assets112513567741,84584555400
Intangible Assets0000000000
Investments & Other62,95630,74930,14530,12530,36825,87627,43329,74627,74331,037
Debtors (Due After 1 year)0000000000
Total Fixed Assets62,95730,87430,14730,48131,14227,72228,27830,30027,74331,038
Stock & work in progress0000000000
Trade Debtors3,87501,3413,4074,1245,43610,4583,28703,076
Group Debtors0000000000
Misc Debtors0000000000
Cash17,3853,6922,81416,8271222,1443,3471,78277727
misc current assets0000000000
total current assets21,2603,6924,15520,2334,2467,58013,8055,069773,803
total assets84,21834,56634,30250,71435,38835,30242,08335,36927,82034,841
Bank overdraft0000000000
Bank loan0000000000
Trade Creditors 00040,30848,75940,49752,15750,35319,59147,641
Group/Directors Accounts0000000000
other short term finances0000000000
hp & lease commitments0000000000
other current liabilities67,10223,77823,3100000023,1720
total current liabilities67,10323,77923,31140,30848,75940,49752,15750,35342,76347,641
loans0000000000
hp & lease commitments0000000000
Accruals and Deferred Income0000000000
other liabilities0000000000
provisions11000000000
total long term liabilities12000000000
total liabilities67,11523,77923,31140,30848,75940,49752,15750,35342,76347,641
net assets17,10310,78710,99210,406-13,372-5,195-10,074-14,983-14,943-12,800
total shareholders funds17,10310,78710,99210,406-13,372-5,195-10,074-14,983-14,943-12,800
Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Profit7,718-22371229,669-8,2016,3326,459-53-2,132-12,933
Depreciation1231233454701,391257335000
Amortisation0000000000
Tax-1,4810-147-5,9420-1,459-1,553000
Stock0000000000
Debtors3,874-1,341-2,065-717-1,313-5,0217,1703,287-3,0763,076
Creditors00-40,308-8,4518,262-11,6601,80530,762-28,05047,641
Accruals and Deferred Income43,32446823,3100000-23,17223,1720
Deferred Taxes & Provisions11000000000
Cash flow from operations45,8211,709-14,02316,4632,765-1,509-1244,250-3,93431,632
Investing Activities
capital expenditure1-24710-52-320-1,257-625-55400
Change in Investments32,20760421-2434,492-1,556-2,3132,003-3,29531,037
cash flow from investments-32,206-851-11191-4,8122991,688-2,5573,295-31,037
Financing Activities
Bank loans0000000000
Group/Directors Accounts0000000000
Other Short Term Loans 0000000000
Long term loans0000000000
Hire Purchase and Lease Commitments0000000000
other long term liabilities0000000000
share issue03-3919-7-108-14131
interest7916254261413522
cash flow from financing79192251257313-12133
cash and cash equivalents
cash13,694878-14,01216,705-2,022-1,2031,5641,706-650727
overdraft0000000000
change in cash13,694878-14,01216,705-2,022-1,2031,5641,706-650727

apoplexa limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for apoplexa limited. Get real-time insights into apoplexa limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Apoplexa Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for apoplexa limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other micro companies, companies in B18 area or any other competitors across 12 key performance metrics.

apoplexa limited Ownership

APOPLEXA LIMITED group structure

Apoplexa Limited has no subsidiary companies.

Ultimate parent company

APOPLEXA LIMITED

05013482

APOPLEXA LIMITED Shareholders

mr thomas mueller 100%

apoplexa limited directors

Apoplexa Limited currently has 1 director, Mr Thomas Mueller serving since Jan 2004.

officercountryagestartendrole
Mr Thomas MuellerGermany59 years Jan 2004- Director

P&L

December 2018

turnover

16k

0%

operating profit

7.7k

0%

gross margin

16.6%

0%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2018

net assets

17.1k

+0.59%

total assets

84.2k

+1.44%

cash

17.4k

+3.71%

net assets

Total assets minus all liabilities

apoplexa limited company details

company number

05013482

Type

Private limited with Share Capital

industry

82990 - Other business support service activities n.e.c.

incorporation date

January 2004

age

21

incorporated

UK

ultimate parent company

None

accounts

Micro-Entity Accounts

last accounts submitted

December 2018

previous names

N/A

accountant

-

auditor

-

address

69 great hampton street, birmingham, west midlands, B18 6EW

Bank

-

Legal Advisor

-

apoplexa limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to apoplexa limited.

apoplexa limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for APOPLEXA LIMITED. This can take several minutes, an email will notify you when this has completed.

apoplexa limited Companies House Filings - See Documents

datedescriptionview/download